Esperion Therapeutics, Inc. (NASDAQ:ESPR) Sees Large Increase in Short Interest
Esperion Therapeutics, Inc. (NASDAQ:ESPR – Get Free Report) saw a large increase in short interest during the month of August. As of August 15th, there was short interest totalling 41,730,000 shares, an increase of 9.4% from the July 31st total of 38,140,000 shares. Approximately 21.5% of the shares of the company are short sold. Based […]
More Stories
Elevance Health, Inc. (NYSE:ELV) Short Interest Update
Elevance Health, Inc. (NYSE:ELV – Get Free Report) saw a large growth in short interest during the month of September....
Arm Holdings plc (NASDAQ:ARM) Given Average Recommendation of “Moderate Buy” by Analysts
Arm Holdings plc (NASDAQ:ARM – Get Free Report) has been given a consensus recommendation of “Moderate Buy” by the thirty...
AllianceBernstein Holding L.P. (NYSE:AB) Receives Consensus Rating of “Moderate Buy” from Brokerages
AllianceBernstein Holding L.P. (NYSE:AB – Get Free Report) has been given a consensus rating of “Moderate Buy” by the five...
Aerovate Therapeutics, Inc. (NASDAQ:AVTE) Sees Significant Decrease in Short Interest
Aerovate Therapeutics, Inc. (NASDAQ:AVTE – Get Free Report) was the recipient of a large drop in short interest during the...
180 Life Sciences Corp. (NASDAQ:ATNFW) Short Interest Down 15.9% in September
180 Life Sciences Corp. (NASDAQ:ATNFW – Get Free Report) was the recipient of a large decline in short interest in...
DoubleLine Opportunistic Credit Fund (NYSE:DBL) Short Interest Update
DoubleLine Opportunistic Credit Fund (NYSE:DBL – Get Free Report) was the recipient of a large growth in short interest in...